R&D pipeline

To address key scientific issues, genOway designs, develops and markets proprietary innovative genetically modified models. These models are called products. The products target the two main issues in bio-pharmaceutical R&D: predictability and development time, in three fields: gene validation, drug screening and pharmacological - toxicological studies.

Our products have the following characteristics:

	A product targets a scientific question of broad interest for therapeutic areas.
	A product is validated by leading academic laboratories and companies to provide the scientist customer with a clear understanding of the strengths and limits of the products.

The first range of products will help analyze the contribution of immunological causes in human disease such as oncology, metabolic disorders… Partnerships with laboratories to validate models is being implemented.
Other products already under development are targeting other therapeutic areas.